Axsome Therapeutics (AXSM) Breaks Out — Targeting Analyst Price

29
Axsome Therapeutics (AXSM) has just broken out of a multi-month descending trendline, signaling renewed bullish momentum. I will buy at the open, targeting the analyst price target of $176.68 for a potential strong upside move. My stop will be set just below the prior resistance line (~$110), which should now act as support. This setup offers a favorable risk/reward, with the trendline breakout confirming renewed interest and upside potential.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.